Enter inventor name

Los Altos Hills, CA, United States of America

Peter G Milner

This inventor holds 41 USPTO granted patents and 3 published patent applications, primarily in Pharmaceutical Innovations. Top assignees: Aryx Therapeutics, Inc., Conjuchem, Inc., Conjuchem Biotechnologies Inc.. Active years: 1997-2022.

USPTO Granted Patents = 41 (Patent Applications = 3)

% Patents Active = 58.5

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 684(Granted Patents)

Location History:

Santa Rosa, CA (US) (2002)
Los Altos Hills, CA (US) (2000 - 2017)
Los Altos, CA (US) (1997 - 2022)
Los Alamos, CA (US) (2022)

Company Filing History:

19 out of 50

Aryx Therapeutics, Inc.

Conjuchem Biotechnologies Inc.

patents

4. 4 out of 3,046

University of Florida Research Foundation Inc.

Advanced Diagnostics and Discovery

Years Active: 1997-2022

Loading Chart...

Areas of Expertise:

Neurodegenerative Diseases

Cardiac Arrhythmias

Diabetes Treatment

Anti-Obesity Agents

Atrial Fibrillation

Antiviral Peptides

Hypertension

Analgesic Agents

Bioconjugation

Hypnotic Barbiturates

Peptide Protection

Thrombosis Prevention

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11510889 - Methods for inhibiting the progression of neurodegenerative diseases (2022-11-29),

2. 11491130 - Methods of treating amyotrophic lateral sclerosis (2022-11-08),

3. 11351143 - Methods of treating amyotrophic lateral sclerosis (2022-06-07),

4. 9549912 - Methods for treating atrial fibrillation (2017-01-24),

5. RE42412 - Materials and methods for the treatment of gastroesophageal reflux disease (2011-05-30),

6. 7906482 - Anti-obesity agents (2011-03-15),

7. RE41289 - Ultrashort acting hypnotic barbiturates (2010-04-26),

8. 7608271 - Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group (2009-10-27),

9. 7601691 - Anti-obesity agents (2009-10-13),

10. 7582301 - Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides (2009-09-01),

11. 7265142 - Materials and methods for the treatment of hypertension and angina (2007-09-04),

12. 7256253 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2007-08-14),

13. 7090851 - Long lasting fusion peptide inhibitors of viral infection (2006-08-15),

14. 7041673 - Ultrashort acting hypnotic barbiturates (2006-05-09),

15. 7022722 - Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis (2006-04-04),

Title: The Innovative Journey of Peter G Milner

Introduction: Peter G Milner, a distinguished inventor based in Los Altos Hills, CA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Peter G Milner's latest patents showcase his ingenuity and forward-thinking approach to innovation, with a focus on cutting-edge technologies in the digital realm.

Career Highlights: Throughout his illustrious career, Peter G Milner has been at the forefront of technological advancements, consistently pushing the boundaries of what is possible. His innovative spirit and dedication to excellence have earned him a reputation as a visionary in the industry.

Collaborations: Peter G Milner has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly with diverse teams has been instrumental in the success of his projects.

Conclusion: Peter G Milner's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the world of technology is truly remarkable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]